CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California. Show more
360 North Pastoria Avenue, Sunnyvale, CA, 94085, United States
Market Cap
696M
52 Wk Range
$10.01 - $24.33
Previous Close
$18.49
Open
$18.60
Volume
334,388
Day Range
$18.20 - $19.60
Enterprise Value
559M
Cash
159.3M
Avg Qtr Burn
-10.77M
Insider Ownership
12.78%
Institutional Own.
85.27%
Qtr Updated
12/31/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
